AI Designs First Vaccine Tested in Humans
Behold: an actually useful application of AI. Researchers at the University of Cambridge have used a machine learning model to invent a new and wholly novel form of vaccine that could protect against an entire family of human coronaviruses, and even animal variants that are yet to jump over. An initial human trial has already been completed, the results of which were published in the Journal of Infection , making it the first AI-designed vaccine to be tested in humans. The po
Researchers at the University of Cambridge have developed a novel vaccine using artificial intelligence, designed to protect against a broad range of coronaviruses, including potential future strains and animal variants. This marks the first AI-designed vaccine to undergo human trials, with initial results published in the Journal of Infection. The AI model analyzed vast amounts of genetic data to identify stable virus components, enabling the creation of a 'super-antigen' vaccine. This approach aims to provide long-term protection against evolving viruses, unlike traditional vaccines that require frequent updates. The small-scale human trial showed the vaccine successfully stimulated antibody production and was well-tolerated, though further research is needed to assess its efficacy and duration of protection.
This story is significant as it demonstrates a groundbreaking application of AI in healthcare, potentially revolutionizing vaccine development and pandemic preparedness.
📌 Kaynak
Bu özet World kaynağından otomatik derlenmiştir. Tamamı için orijinal habere gidin.
Orijinal haberi oku →